Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials
Article in British Journal of Dermatology (March 2024)
The most recent citing publications are shown below. View all 68 publications that cite this research output on Dimensions.
Article in British Journal of Dermatology (March 2024)
Article in JEADV Clinical Practice (October 2023)
Article in Inflammopharmacology (December 2022)